Matrix Biolage Colorcare therapie
Matrix Biolage Colorcare therapie was recalled on 8 March 2024 under EU Safety Gate alert A12/00607/24. Chemical risk reported by Italy. According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products.
| Alert Number | A12/00607/24 |
| Brand | Matrix |
| Category | Cosmetics |
| Risk Type | Chemical |
| Notifying Country | Italy |
| Country of Origin | United States |
| Published | 8 March 2024 |
Risk Description
According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA can damage the reproductive system, may harm the health of the unborn child and may cause skin sensitisation. The product does not comply with the Cosmetic Products Regulation.
Measures Taken
Type of economic operator to whom the measure(s) were ordered: DistributorCategory of measure(s): Ban on the marketing of the product and any accompanying measuresDate of entry into force: 12/04/2023
Product Description
Mask cream marketed for coloured hair, 150 ml.
🧪 What Should You Do?
This recall involves a chemical hazard related to Matrix Biolage Colorcare therapie.
About this risk
This product contains prohibited or hazardous chemical substances that may cause skin irritation, allergic reactions, or long-term health effects.
Recommended action
Stop using the product immediately. Wash any skin that has come into contact with it. Keep it away from children. Return it to the retailer for a refund if possible.
Who is at risk?
Anyone who has used this product, especially children, pregnant women, and people with sensitive skin.